Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building
₹ 1550.52
₹ 741
20
₹ 14,820.00
MumbaiNSE
04-Aug-2023
08-Aug-2023
18-Aug-2023
1 Week | -0.52 |
1 Month | 11.94 |
3 Month | -5.89 |
6 Month | 34.98 |
1 Year | 60.35 |
Initial public offer of 20,925,652* equity shares of face value of Re. 1 each (Equity Shares) of Concord Biotech Limited (Company) for cash at a price of Rs. 741 per equity share (including a premium of Rs. 740 per equity share) (Offer Price) aggregating to Rs. 1550.52*^ crores (the Offer) through an offer for sale of 20,925,652* equity shares aggregating to Rs. 1550.52*^ crores by Helix Investment Holdings Pte. Limited (the Selling Shareholder) and such equity shares offered by the selling shareholder, the (Offered Shares).The offer includes a reservation of 10,000* equity shares, aggregating to Rs. 0.67^ crores (constituting 0.01% of the post-offer paid-up equity share capital), for subscription by eligible employees (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as Net Offer. The offer and net offer constitute 20% and 19.99%, of the post-offer paid-up equity share capital of the company, respectively. The face value of equity shares is Re. 1 each. The offer price is Rs. 741 times the face value.*Subject to finalisation of basis of allotment.^A discount of Rs. 70 per equity share was offered to eligible employees bidding in the employee reservation portion.
Listing the Equity Shares on the Stock Exchanges.
Concord Biotech Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - complianceofficer@concordbiotech.com
Website - www.concordbiotech.com